Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: A pre-defined analysis from the CARE-HF trial

European Heart Journal

Volumn 28, Issue 15, 2007, Pages 1827-1834

  Richardson, Matthew ^a   Freemantle, Nick ^a   Calvert, Melanie J ^a   Cleland, John G F ^b   Tavazzi, Luigi ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CASTLE HILL HOSPITAL   (United Kingdom)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Cardiac resynchronization therapy; Prognostic model

Indexed keywords

AGED; BLOOD PRESSURE; CARDIAC PACING, ARTIFICIAL; HEART FAILURE; HUMANS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SYSTOLE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34547787675     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm192     Document Type: Article

References (32)

1. Cleland JGF, Gemmel I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail 1999;1:229-241.
2. Xiao HB, Brecker SJD, Gibson DG. Differing effects of right ventricular pacing and left bundle branch block on left ventricular function. Br Heart J 1993;69:166-173.
3. Daubert JC, Cazeau S, Leclercq C. Do we have reasons to be enthusiastic about pacing to treated advanced heart failure? Eur J Heart Fail 1999;1:281-287.
4. Auricchio A, Klein H, Spinelli J. Pacing for heart failure: selection of patients, techniques and benefits. Eur J Heart Fail 1999;1:275- 279.
5. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J, MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
6. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, for the Comparison of Medical Therapy, Pacing, Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
7. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization- Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
8. Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JGF. Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction - a systematic review and meta-analysis. Eur J Heart Fail 2006;8:433-440.
9. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L Klein W, Tavazzi L, on behalf of the CARE-HF Study Steering Committee Investigators. The CARE-HF study (CArdiac REsynchronization in Heart Failure study): rationale, design and end-points. Eur J Heart Fail 2001;3:481-489.
10. Ghio S, Freemantle N, Serio A, Magrini G, Scelsi L, Pasotti M, Cleland JGF, Tavazzi L. Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study). Eur J Echocardiogr 2006;7:373-378.
11. Talwar S, Squire B, Davies JE, Barnett DB, Ng LL. Plasma N-terminal probrain natriuretic peptide and the ECG in the assessment of leftventricular systolic dysfunction in a high risk population. Eur Heart J 1999;20:1736-1777.
12. Pitzalis MV, Iacoviello M, Romito R, Guida P, De Tommasi E, Luzzi G, Anaclerio M, Forleo C, Rizzon P. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. J Am Coll Cardiol 2005;45:65-69.
13. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005;330:625-635.
14. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression of Time to Event Data. Wiley; 1992.
15. Lee ET. Statistical Methods For Survival Data Analysis. 2nd ed. John Wiley & Sons, Inc; 1992. ISBN 0-471-61592-7.
16. Harrell FE Jr, Lee KL, Matchar DB, Reichert T. Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep 1985;69:1071-1077.
17. Harrell FE Jr, Lee KL, Mark DB. Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and measuring and reducing errors. Stat Med 1996;15:361-387.
18. Ambler G, Brady AR, Royston P. Simplifying a prognostic model: a simulation study based on clinical data. Stat Med 2002;21:3803- 3822.
19. May M, Royston P, Egger M, Justice A, Sterne J. Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy. Stat Med 2004;23:2375-2398.
20. Harrell FE Jr, Herndon JE. The Restricted Cubic Spline Hazard Model. Commun Statist Theory Meth 1990;19:639-663.
21. Wegman EJ, Wright IW. Splines in statistics. J Am Stat Ass 1983;78:351-365.
22. Poirier DJ. Piecewise regression using cubic spline. J Am Stat Ass 1973;68:515-524.
23. Smith PL. Splines as a useful and convenient statistical tool. American Statistician 1979;33:57-62.
24. Royston P. Choice of scale for cubic smoothing spline models in medical applications. Stat Med 2000;19:1191-1205.
25. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control 1974;19:716-723.
26. Verweij PJM, van Houwelingen HC, Stijnen T. A goodness of fit test for Cox's Proportional Hazards Model based on martingale residuals. Biometrics 1998;54:1517-1526.
27. Therneau TM, Grambsch PM. Martingale-based residuals for survival models. Biometrika 1990;77:147-160.
28. Heinzl H, Kaider A. Manual for the SAS-Macro RCS (Version 2. 0). Technical Report KB 1-96. Universitat Wien, Institut fur Medizinische Computerwissenschaften Abteilung fur Klinische Biometrie.
29. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials (ICH E9). Stat Med 1999;18:1905-1942.
30. Overview of Design Library. http://lib.stat.cmu.edu/S/Harrell/help/ Design/html/Overview. (19 February 2007).
31. SAS Institute. The MI Procedure. http://support.sas.com/rnd/app/ papers/miv802.pdf (19 February 2007).
32. Ghio S, Constantin C, Klersy C, Serio A, Fontana A, Campana C, Tavazzi L. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J 2004;25:571-578.